Literature DB >> 2910914

Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells.

M F Norman1, T N Lavin.   

Abstract

A thyroid hormone antagonist has not been previously described. A number of thyroid hormone analogues have been shown to compete with [125I]triiodothyronine ([125I]T3) for binding to the intranuclear thyroid hormone receptor and to have agonist activity proportional to their affinities for the receptors. We report that the benzofuran amiodarone acts as a competitive antagonist to thyroid hormone action as defined by its dose-dependent ability to (a) bind to the thyroid hormone receptor and (b) inhibit T3-induced increases in growth hormone mRNA levels in a cultured rat pituitary cell line, GC cells. Like T3 itself, amiodarone also decreases transport of [125I]T3 across GC cell membranes. An analysis of the amiodarone structure suggests that this compound has certain similarities to T3. These findings hold promise for the development of other thyroid hormone antagonists for clinical use and for understanding thyroid hormone action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910914      PMCID: PMC303675          DOI: 10.1172/JCI113874

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  L-Triiodothyronine (T3) stimulates growth of cultured GC cells by action early in the G1 period: evidence for mediation by the nuclear T3 receptor.

Authors:  C R DeFesi; E C Fels; M I Surks
Journal:  Endocrinology       Date:  1985-05       Impact factor: 4.736

Review 2.  Amiodarone.

Authors:  J W Mason
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

3.  Stereospecific transport of triiodothyronine to cytoplasm and nucleus in GH1 cells.

Authors:  H C Freake; A D Mooradian; H L Schwartz; J H Oppenheimer
Journal:  Mol Cell Endocrinol       Date:  1986-01       Impact factor: 4.102

4.  Amiodarone and thyroid hormone action.

Authors:  J A Franklyn; J R Davis; M D Gammage; W A Littler; D B Ramsden; M C Sheppard
Journal:  Clin Endocrinol (Oxf)       Date:  1985-03       Impact factor: 3.478

5.  Hormonal regulation of the growth hormone gene. Relationship of the rate of transcription to the level of nuclear thyroid hormone-receptor complexes.

Authors:  B M Yaffe; H H Samuels
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

6.  Transcellular and transnuclear transport of 3,5,3'-triiodothyronine in isolated hepatocytes.

Authors:  A D Mooradian; H L Schwartz; C N Mariash; J H Oppenheimer
Journal:  Endocrinology       Date:  1985-12       Impact factor: 4.736

7.  The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5'-monodeiodination in rats.

Authors:  P B Sogol; J M Hershman; A W Reed; W H Dillmann
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

8.  Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors.

Authors:  K R Latham; D F Sellitti; R E Goldstein
Journal:  J Am Coll Cardiol       Date:  1987-04       Impact factor: 24.094

9.  Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats.

Authors:  K Y Hostetler; M J Reasor; E R Walker; P J Yazaki; B W Frazee
Journal:  Biochim Biophys Acta       Date:  1986-02-12

10.  Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.

Authors:  T A Plomp; W M Wiersinga; R A Maes
Journal:  Arzneimittelforschung       Date:  1985
View more
  9 in total

1.  T-screen and yeast assay for the detection of the thyroid-disrupting activities of cadmium, mercury, and zinc.

Authors:  Jian Li; Yun Liu; Dongdong Kong; Shujuan Ren; Na Li
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-09       Impact factor: 4.223

2.  Models for the binding of amiodarone to the thyroid hormone receptor.

Authors:  D K Chalmers; S L Munro; M N Iskander; D J Craik
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

Review 3.  Amiodarone-induced thyroid disorders: a clinical review.

Authors:  K C Loh
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

4.  Interaction of amiodarone and triiodothyronine on the expression of beta-adrenoceptors in brown adipose tissue of rat.

Authors:  H Adli; R Bazin; G Y Perret
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 5.  Physiological role and regulation of iodothyronine deiodinases: a 2011 update.

Authors:  A Marsili; A M Zavacki; J W Harney; P R Larsen
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

6.  In vitro and in silico approach to study the hormonal activities of the alternative plasticizer tri-(2-ethylhexyl) trimellitate TEHTM and its metabolites.

Authors:  Laurence Dahbi; Amaury Farce; Nicolas Kambia; Isabelle Séverin; Thierry Dine; Emmanuel Moreau; Valérie Sautou; Marie-Christine Chagnon
Journal:  Arch Toxicol       Date:  2022-01-28       Impact factor: 5.153

7.  Screening for drugs potentially interfering with MCT8-mediated T3 transport in vitro identifies dexamethasone and some commonly used drugs as inhibitors of MCT8 activity.

Authors:  C Di Cosmo; G De Marco; P Agretti; E Ferrarini; A Dimida; P Falcetta; S Benvenga; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2021-11-30       Impact factor: 4.256

8.  Uptake of amiodarone by thyroidal and non-thyroidal cell lines.

Authors:  F Bogazzi; F Raggi; F Ultimieri; D Russo; C Cosci; P Cecchetti; E Dell'Unto; C Sardella; M Tonacchera; P Vitti; L Benzi; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

9.  Limited Chemical Structural Diversity Found to Modulate Thyroid Hormone Receptor in the Tox21 Chemical Library.

Authors:  Katie Paul-Friedman; Matt Martin; Kevin M Crofton; Chia-Wen Hsu; Srilatha Sakamuru; Jinghua Zhao; Menghang Xia; Ruili Huang; Diana A Stavreva; Vikas Soni; Lyuba Varticovski; Razi Raziuddin; Gordon L Hager; Keith A Houck
Journal:  Environ Health Perspect       Date:  2019-09-30       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.